Accès à distance ? S'identifier sur le proxy UCLouvain
Combination of gemcitabine and cetuximab in patients with advanced cholangiocarcinoma: a phase II study of the Belgian Group of Digestive Oncology
Primary tabs
- Open access
- 161.47 K
Document type | Article de périodique (Journal article) – Article de recherche |
---|---|
Access type | Accès libre |
Publication date | 2013 |
Language | Anglais |
Journal information | "Annals of Oncology" - Vol. 24, no.11, p. 2824-2829 (2013) |
Peer reviewed | yes |
Publisher | Oxford University Press ((United Kingdom) Oxford) |
issn | 0923-7534 |
e-issn | 1569-8041 |
Publication status | Publié |
Affiliations |
UCL
- SSS/IREC/GAEN - Pôle d'Hépato-gastro-entérologie UCL - (SLuc) Service d'hépato-gastro-entérologie UCL - (SLuc) Centre du cancer UCL - (SLuc) Service d'anatomie pathologique |
MESH Subject | Adult ; Female ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Proto-Oncogene Proteins ; ras Proteins ; Aged ; Aged, 80 and over ; Antibodies, Monoclonal, Humanized ; Antineoplastic Combined Chemotherapy Protocols ; Bile Duct Neoplasms ; Cholangiocarcinoma ; Deoxycytidine ; Disease-Free Survival |
Links |
Bibliographic reference | Borbath, Ivan ; Ceratti, Antonino ; Verslype, Chris ; Demols, Anne ; Delaunoit, Thierry ; et. al. Combination of gemcitabine and cetuximab in patients with advanced cholangiocarcinoma: a phase II study of the Belgian Group of Digestive Oncology. In: Annals of Oncology, Vol. 24, no.11, p. 2824-2829 (2013) |
---|---|
Permanent URL | http://hdl.handle.net/2078.1/156079 |